Literatur

Schmoll H.-J., Höffken K., Possinger K. (Hrsg.): Kompendium Internistische Onkologie. Standards in der Diagnostik und Therapie; Teil 2 Therapiekonzepte maligner Tumore; 4. Auflage 2006: Kapitel zum Hodgkin Lymphom.

Springer Lexikon Diagnose und Therapie: Kapitel zum Hodgkin Lymphom. 1. Auflage 2006:

Der Onkologe: Band 11. Heft 9. September 2005, Springer Verlag.

Diehl V., Josting A. (Eds.): 25 Years German Hodgkin Study Group. Urban und Fischer Verlag, München 2004.

Fuchs M., Diehl V., Re D.: Current strategies and new approaches in the treatment of Hodgkin's Lymphoma. Pathobiology 2006. 73 (3): p. 126-40.

Borchmann P., Behringer K, Josting A. et al.: Sekundärneoplasien nach erfolgreicher Therapie des malignen Hodgkin Lymphoms. Pathologe 2006. 27: p. 47-52.

Engert A., Plütschow A., Eich HT. et al.: Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med. 2010. 363:640-52.

Josting A., Müller H., Borchmann P. et al.: Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma. J Clin Oncol. 2010. 28:5074-80.

Behringer K., Wildt L., Mueller H. et al.: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. 2010. 21:2052-60.

Halbsguth T.V., Nogová L., Mueller H. et al.: Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).Blood. 2010.116:2026-32.

Kobe C., Dietlein M., Franklin J. et al.: Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.Blood. 2008.112:3989-94.

Engert A, Eichenauer DA, Dreyling M; ESMO Guidelines Working Group: Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010.21 Suppl 5:v168-71.

FertiPROTEKT: http://www.fertiprotekt.de

Deutsche Fatigue Gesellschaft:http://www.deutsche-fatigue-gesellschaft.de

Übersicht Hodgkin Lymphom auf www.lymphome.de